Nanoparticle comprising rapamycin and albumin as anticancer agent

Details for Australian Patent Application No. 2008223334 (hide)

Owner ABRAXIS BIOSCIENCE, LLC.

Inventors Desai, Neil P.; Soon-Shiong, Patrick; Trieu, Vuong

Agent A J Park

Pub. Number AU-A-2008223334

PCT Pub. Number WO2008/109163

Priority 60/923,456 13.04.07 US; 60/905,663 07.03.07 US; 60/923,248 13.04.07 US; 60/905,750 07.03.07 US; 60/905,787 07.03.07 US; 60/905,767 07.03.07 US; 60/905,662 07.03.07 US; 60/905,735 07.03.07 US; 60/905,672 07.03.07 US; 60/905,734 07.03.07 US; 60/905,669 07.03.07 US

Filing date 7 March 2008

Wipo publication date 12 September 2008

International Classifications

A61K 9/51 (2006.01) Medicinal preparations characterised by special physical form - Nanocapsules

A61K 31/436 (2006.01)

A61K 47/42 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

29 October 2009 PCT application entered the National Phase

  PCT publication WO2008/109163 Priority application(s): WO2008/109163

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008223338-Variant activin receptor polypeptides and uses thereof

2008223333-Combined open loop/closed loop method for controlling uplink power of a mobile station